{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:18:37Z","timestamp":1772273917852,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Dement."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dementia with Lewy bodies (DLB) is the second most common type of neurodegenerative dementia. Here, we report a case of dementia associated with anti-Rho-GTPase-activating protein 26 (ARHGAP26) autoantibodies, which have never been previously linked to DLB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We describe the case of a 78-year-old man who underwent cerebrospinal fluid (CSF) analysis, magnetic resonance imaging (MRI), <jats:sup>18<\/jats:sup>F-fluorodesoxyglucose positron emission tomography (FDG-PET), and a detailed neuropsychological evaluation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The patient presented with mild dementia syndrome associated with extrapyramidal symptoms. Neuropsychological testing revealed impaired cognitive flexibility, figural memory, and verbal memory. Fluctuating cognitive abilities with deficits in attention-executive dysfunction and visuoconstruction also developed over time. A brain MRI showed reduced biparietal and cerebellar brain volume with generalized accentuation of the outer CSF spaces. The patient's CSF revealed anti-ARHGAP26 autoantibodies, which were also detectable in serum. In the differential complementary imaging diagnosis at 2 years, an FDG-PET revealed decreased occupancy of the posterior cingulum and precuneus. Although the FDG-PET, MRI, and clinical findings were potentially consistent with Alzheimer's disease, negative amyloid biomarkers in the CSF made an AD diagnosis highly unlikely. Single photon emission computed tomography (SPECT) with [(123)I] N-omega-fluoropropyl-2beta-carbomethoxy-3beta-{4-iodophenyl}nortropane ([(123)I]FP-CIT) showed right-sided predominance, reduced dopamine transporter uptake in the putamen, consistent with a positive indicative biomarker finding typical of DLB. Considering the clinically probable DLB associated with the two core features of Parkinsonism and fluctuating cognition with deficits in attention, supported by an abundant tracer uptake in the right putamen and lower uptake in the left putamen on 123I-FP-CIT-SPECT as an indicative biomarker, we started an antidementia drug using a cholinesterase inhibitor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our report shows that atypical DLB may be associated with anti-ARHGAP26 autoantibodies, although their role and significance in the pathogenesis of DLB are unknown. However, it has to be mentioned that it is also possible that antibody-specific synthesis of anti-ARHGAP26 autoantibodies is a hallmark of a rare autoimmune disease that may cause the clinical and laboratory features involving altered dopamine transporter uptake on 123I-FP-CIT-SPECT, dementia, and mild Parkinson's symptoms rather than idiopathic DLB with only two core DLB features and inconsistent cognitive and imaging findings. Further research is needed to investigate the role of these autoantibodies in different dementias, particularly in DLB and mixed DLB-AD types.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frdem.2023.1227823","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:02:46Z","timestamp":1691103766000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Anti-ARHGAP26 autoantibodies in atypical dementia with Lewy bodies"],"prefix":"10.3389","volume":"2","author":[{"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn Hendrik","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41398-020-00954-8","article-title":"Neuroinflammation in dementia with Lewy bodies: a human post-mortem study","volume":"10","author":"Amin","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fneur.2018.00656","article-title":"Anti-ARHGAP26 autoantibodies are associated with isolated cognitive impairment","volume":"9","author":"Bartels","year":"2018","journal-title":"Front. Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e200137","DOI":"10.1212\/NXI.0000000000200137","article-title":"Antibodies associated with autoimmune encephalitis in patients with presumed neurodegenerative dementia","volume":"10","author":"Bastiaansen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0236-0","article-title":"SMURF1-mediated ubiquitination of ARHGAP26 promotes ovarian cancer cell invasion and migration","volume":"51","author":"Chen","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbi.2022.10.016","article-title":"Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: analysis of 49 autoantibodies in over 7000 subjects","volume":"108","author":"Daguano Gastaldi","year":"2022","journal-title":"Brain Behav. Immun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann. Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2013.10.010","article-title":"Anti-Ca\/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline","volume":"267","author":"Doss","year":"2014","journal-title":"J. Neuroimmunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.abf7266","article-title":"CD4+ T cells contribute to neurodegeneration in Lewy body dementia","volume":"374","author":"Gate","year":"2021","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.jtauto.2022.100167","article-title":"Increased T- and B-cells associated with the phenotype of autoimmune limbic encephalitis with mainly memory dyfunction","volume":"5","author":"Hansen","year":"2022","journal-title":"J. Trans. Autoimmun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1128\/MCB.16.6.3169","article-title":"An SH3 domaincontaining GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase","volume":"16","author":"Hildebrand","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.11477\/mf.1416200239","article-title":"[A patient with probable dementia with lewy bodies and positive autoantibodies against the anti-NH2-terminal of \u03b1-enolase]","volume":"67","author":"Ikura","year":"2015","journal-title":"Brain Nerve"},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1007\/s00415-022-11178-9","article-title":"Rho GTPase-activating protein 10 (ARHGAP10\/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis","volume":"269","author":"Jarius","year":"2022","journal-title":"J. Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-015-0357-x","article-title":"\u2018Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. part 2: anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC","volume":"12","author":"Jarius","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awab402","article-title":"Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups","volume":"145","author":"Kaivola","year":"2022","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"102754","DOI":"10.1016\/j.nicl.2021.102754","article-title":"FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD","volume":"31","author":"Kantarci","year":"2021","journal-title":"Neuroimage Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0171802","DOI":"10.1371\/journal.pone.0171802","article-title":"Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/JAD-2011-110221","article-title":"Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias","volume":"26","author":"Maetzler","year":"2011","journal-title":"J. Alzheimers Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0166-2236(00)02118-4","article-title":"Rho proteins, mental retardation and the cellular basis of cognition","volume":"25","author":"Ramakers","year":"2002","journal-title":"Trends. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1007\/s00415-023-11632-2","article-title":"Untreated anti-Ca\/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years","volume":"270","author":"Schegk","year":"2023","journal-title":"J. Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/0891988715590210","article-title":"The relationship between medial temporal lobe atrophy and cognitive impairment in patients with dementia with lewy bodies","volume":"28","author":"Tagawa","year":"2015","journal-title":"J. Geriatr. Psychiatry Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2017.05.011","article-title":"From dizziness to severe ataxia and dysarthria: new cases of anti-Ca\/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum","volume":"309","author":"Wallwitz","year":"2017","journal-title":"J. Neuroimmunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"729076","DOI":"10.3389\/fcell.2021.729076","article-title":"Rho signaling in synaptic plasticity, memory, and brain disorders","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol"}],"container-title":["Frontiers in Dementia"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frdem.2023.1227823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:02:56Z","timestamp":1691103776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frdem.2023.1227823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":27,"alternative-id":["10.3389\/frdem.2023.1227823"],"URL":"https:\/\/doi.org\/10.3389\/frdem.2023.1227823","relation":{},"ISSN":["2813-3919"],"issn-type":[{"value":"2813-3919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"article-number":"1227823"}}